Mirjam Langeveld

Research output

Research output per year 2005 2017 2018 2019 2020 2021 2022 2023

• 54 Article
• 8 Review article
• 3 Comment/Letter to the editor
• 2 Other contribution
• 2 More
  • 1 Chapter
  • 1 Phd-Thesis - Research and graduation internal

Research output per year

Research output per year

Search results

• 2022

  Antibodies against recombinant enzyme in the treatment of Fabry disease: Now you see them, now you don't

  van der Veen, S. J. & Langeveld, M., 8 Dec 2022, In: Molecular Therapy - Methods and Clinical Development. 27, p. 324-326 3 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
• 2019

  Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data

  Körver, S., Feldt-Rasmussen, U., Svarstad, E., Kantola, I. & Langeveld, M., Nov 2019, In: Clinical pharmacology and therapeutics. 106, 5, p. 925-926

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  3 Citations (Scopus)
• 2017

  Issues with European guidelines for phenylketonuria

  Burgard, P., Ullrich, K., Ballhausen, D., Hennermann, J. B., Hollak, C. E. M., Langeveld, M., Karall, D., Konstantopoulou, V., Maier, E. M., Lang, F., Lachmann, R., Murphy, E., Garbade, S., Hoffmann, G. F., Kölker, S., Lindner, M. & Zschocke, J., 2017, In: Lancet. Diabetes and endocrinology. 5, 9, p. 681-683

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  19 Citations (Scopus)